Show simple item record

dc.contributor.authorShaw, TJ
dc.contributor.authorRognoni, E
dc.date.accessioned2020-11-12T09:29:51Z
dc.date.available2020-04-23
dc.date.available2020-11-12T09:29:51Z
dc.date.issued2020-06-19
dc.identifier.citationShaw, T.J., Rognoni, E. Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease. Curr Rheumatol Rep 22, 33 (2020). https://doi.org/10.1007/s11926-020-00903-wen_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/68220
dc.description.abstractPURPOSE OF REVIEW: Fibroblasts, the major cell population in all connective tissues, are best known for their role in depositing and maintaining the extracellular matrix. Recently, numerous specialised functions have been discovered revealing unpredicted fibroblast heterogeneity. We will discuss this heterogeneity, from its origins in development to alterations in fibrotic disease conditions. RECENT FINDINGS: Advances in lineage tracing and single-cell transcriptional profiling techniques have revealed impressive diversity amongst fibroblasts in a range of organ systems including the skin, lung, kidney and heart. However, there are major challenges in assimilating the findings and understanding their functional significance. Certain fibroblast subsets can make specific contributions to healthy tissue functioning and to fibrotic disease processes; thus, therapeutic manipulation of particular subsets could be clinically beneficial. Here we propose that four key variables determine a fibroblast's phenotype underpinning their enormous heterogeneity: tissue status, regional features, microenvironment and cell state. We review these in different organ systems, highlighting the importance of understanding the divergent fibroblast properties and underlying mechanisms in tissue fibrosis.en_US
dc.format.extent33 - ?
dc.languageeng
dc.relation.ispartofCurrent Rheumatology Reports
dc.rightsCreative Commons Attribution 4.0 International License
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCell heterogeneityen_US
dc.subjectFibroblasten_US
dc.subjectFibrosisen_US
dc.subjectMyofibroblasten_US
dc.subjectSingle-cell transcriptomicsen_US
dc.subjectTissue injuryen_US
dc.titleDissecting Fibroblast Heterogeneity in Health and Fibrotic Disease.en_US
dc.typeArticleen_US
dc.rights.holder(c) The Author(s) 2020
dc.identifier.doi10.1007/s11926-020-00903-w
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/32562113en_US
pubs.issue8en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume22en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
qmul.funderDefining dermal fibroblast lineage function and identity during development and disease::European Molecular Biology Organizationen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International License
Except where otherwise noted, this item's license is described as Creative Commons Attribution 4.0 International License